Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Eupraxia Pharmaceuticals Inc T.EPRX

Alternate Symbol(s):  T.EPRX.W.A | EPRX | T.EPRX.W

Eupraxia Pharmaceuticals Inc. is a Canada-based clinical-stage biotechnology company. The Company is focused on the development of locally delivered, extended-release alternatives to approved drugs. The Company’s principal business is the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product candidate, EP-104IAR, is designed to meet the unmet medical need and market demand for long-lasting pain relief for knee osteoarthritis (OA). The primary active ingredient of the EP-104 products consists of a solid core of fluticasone propionate (FP) coated with an outer layer of polyvinyl alcohol (PVA). Its lead product candidate is used for the treatment of osteoarthritis and eosinophilic esophagitis symptoms and is used corticosteroid with systemic safety record. EP-104 is in Phase Ib/IIa clinical development.


TSX:EPRX - Post by User

Post by kindvalueon Aug 17, 2021 4:15pm
754 Views
Post# 33718451

destruction

destruction EPRX CFO was at Tekmira which held the delivery technology for the RNAi vaccines
Tekmira is now Arbutus
we are talking about the delivery for Moderna and others
the Tekmira team while he was there, decided to massively overpay to get into a hepatitis pre clinical technology and moneitized (sold for near nothing) the majority ownership of the RNAi delivery 
actually a good article out on the RNAi technology that was given away
https://www.forbes.com/sites/nathanvardi/2021/08/17/covids-forgotten-hero-the-untold-story-of-the-scientist-whose-breakthrough-made-the-vaccines-possible/?sh=1ea506aa354f

massive destruction of shareholders wealth is on your team 


Bullboard Posts
Next >>